GGrantIndex
Sort

141,003 grants matching cytokine

Stem Cells And The Origins of Barrett's Esophagus

$1,204,597
Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2014 · CA

IBD--GENETIC AND IMMUNOPATHOLOGIC MECHANISMS

$1,204,536
Cedars-Sinai Medical Center · P01 · FY2001 · DK

Integrative analysis and modeling of human immune responses and pathologies

$1,204,175
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

INFLAMMATORY CELLS AND LUNG INJURY

$1,204,119
University Of Michigan At Ann Arbor · P01 · FY2002 · HL

Methamphetamine Pharmacotherapy Development Center

$1,203,803
California Pacific Med Ctr Res Institute · P50 · FY2005 · DA

Receptor Mediated Erythropoietin Metabolic Response and Gender Specific Activity

$1,203,693
Constance Noguchi · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Antibody-triggered mouse models of neuropsychiatric lupus: heterogeneity, mechanisms and therapeutic approaches

$1,203,592
Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2025 · AI

SEARCH FOR SELECTIVE THERAPY OF CML

$1,203,466
Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA

Immuno/Immunogene Therapies for Thoracic Malignancies

$1,203,367
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2009 · CA

Development of a novel adjuvant for vaccine sparing

$1,203,147
Sara Lustigman · New York Blood Center · R01 · FY2014 · AI

Embryonic Stem Cell-Derived Platelets as Cellular Therapeutics

$1,203,092
Mortimer Poncz · Children'S Hosp Of Philadelphia · U01 · FY2015 · HL

Signal Transduction in T cell development, function and aging

$1,203,068
Jyoti Sen · Aging · Z01 · FY2007 · AG

Dynamic regulatory network models of human response to influenza virus

$1,202,266
Ivan Marazzi · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · AI

Mechanisms of Alcoholic Liver Disease

$1,202,007
Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA

NADPH Oxidases as Novel Targets for Cancer Therapy

$1,201,732
James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

ACUTE INFECTION AND EARLY DISEASE RESEARCH NETWORK

$1,201,678
Johns Hopkins University · U01 · FY2000 · AI

IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis

$1,201,534
Dominick Auci · Therapyx, Inc. · R44 · FY2023 · DK

Immunologic Mechanisms of Alcoholic Liver Disease

$1,201,402
Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA

Innate immunity and cytokines in liver diseases

$1,201,402
Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA

NADPH Oxidases as Novel Targets for Cancer Therapy

$1,201,276
James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Immunogenetic Mechanisms of Experimental Crohn's Disease

$1,201,225
Steven M Cohn · University Of Virginia · P01 · FY2008 · DK

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,200,776
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,200,776
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Immuno/Immunogene Therapies for Thoracic Malignancies

$1,200,734
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2008 · CA

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection

$1,200,690
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI